These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2518608)

  • 21. Trypanocidal nitroarene treatment of experimental Trypanosoma cruzi infection does not prevent progression of chronic-phase heart lesions in rabbits.
    Teixeira AR; Cunha Neto E; Rizzo LV; Silva R
    J Infect Dis; 1990 Dec; 162(6):1420. PubMed ID: 2121842
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of nifurtimox treatment of chronic Chagas disease by means of several parasitological methods.
    Muñoz C; Zulantay I; Apt W; Ortiz S; Schijman AG; Bisio M; Ferrada V; Herrera C; Martínez G; Solari A
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4518-23. PubMed ID: 23836179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental chemotherapy of Trypanosoma cruzi infection: persistence of parasite antigens and positive serology in parasitologically cured mice.
    Andrade SG; Freitas LA; Peyrol S; Pimentel AR; Sadigursky M
    Bull World Health Organ; 1991; 69(2):191-7. PubMed ID: 1907221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etiological drug treatment of human infection by Trypanosoma cruzi.
    Levi GC; Lobo IM; Kallás EG; Amato Neto V
    Rev Inst Med Trop Sao Paulo; 1996; 38(1):35-8. PubMed ID: 8762637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives.
    Braga MS; Lauria-Pires L; Argañaraz ER; Nascimento RJ; Teixeira AR
    Rev Inst Med Trop Sao Paulo; 2000; 42(3):157-61. PubMed ID: 10887376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives.
    Urbina JA
    J Eukaryot Microbiol; 2015; 62(1):149-56. PubMed ID: 25284065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etiological treatment for infection by Trypanosoma cruzi.
    Amato Neto V
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():337-9. PubMed ID: 10677751
    [No Abstract]   [Full Text] [Related]  

  • 28. The efficacy of a novel compound, (e)-1-(4'-bromo-4-biphenylyl)-1-(4-chlorophenyl)-3-dimethylaminoprop-1-ene against Trypanosoma cruzi in mice.
    Barrett PA; Beveridge E; Bull D; Caldwell IC; Islip PJ; Neal RA; Woods NC
    Experientia; 1982 Mar; 38(3):338-9. PubMed ID: 6804255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina.
    Sosa Estani S; Segura EL
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():363-5. PubMed ID: 10677756
    [No Abstract]   [Full Text] [Related]  

  • 30. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains.
    Veloso VM; Carneiro CM; Toledo MJ; Lana M; Chiari E; Tafuri WL; Bahia MT
    Mem Inst Oswaldo Cruz; 2001 Oct; 96(7):1005-11. PubMed ID: 11685270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV.
    Gruendling AP; Massago M; Teston AP; Monteiro WM; Kaneshima EN; Araújo SM; Gomes ML; Barbosa Md; Toledo MJ
    Am J Trop Med Hyg; 2015 Jun; 92(6):1178-89. PubMed ID: 25940197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An update on benznidazole for the treatment of patients with Chagas disease.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic action of MK-436 (2,5-nitroimidazole) on Trypanosoma cruzi infections in mice: a parasitological, serological, histopathological, and ultrastructural study.
    Andrade SG; Silva RC; Santiago CM; Freitas LA
    Bull World Health Organ; 1987; 65(5):625-33. PubMed ID: 3123082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lychnopholide loaded in surface modified polylactide nanocapsules (LYC-PLA-PEG-NC) cure mice infected by Trypanosoma cruzi strain a prototype of resistance to benznidazole and nifurtimox: First insights of its mechanism of action.
    Milagre MM; Torchelsen FKVDS; Pedrosa TCF; Teixeira GM; Sampaio LS; Saúde-Guimarães DA; Branquinho RT; Mosqueira VCF; Lana M
    Exp Parasitol; 2023 Dec; 255():108647. PubMed ID: 37914151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current drug therapy and pharmaceutical challenges for Chagas disease.
    Bermudez J; Davies C; Simonazzi A; Real JP; Palma S
    Acta Trop; 2016 Apr; 156():1-16. PubMed ID: 26747009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of chronic Chagas' disease with an association of nifurtimox and corticoid].
    Rassi A; Amato Neto V; de Siqueira AF; Ferriolli Filho F; Amato VS; Rassi GG; Rassi Junior A
    Rev Soc Bras Med Trop; 2002; 35(6):547-50. PubMed ID: 12612733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Longitudinal study and specific chemotherapy in children with chronic Chagas' disease, residing in a low endemicity area of Argentina].
    Streiger ML; del Barco ML; Fabbro DL; Arias ED; Amicone NA
    Rev Soc Bras Med Trop; 2004; 37(5):365-75. PubMed ID: 15361952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of benznidazole dose among the efficacy outcome in the murine animal model. A quantitative integration of the literature.
    Molina I; Perin L; Aviles AS; de Abreu Vieira PM; da Silva Fonseca K; Cunha LM; Carneiro CM
    Acta Trop; 2020 Jan; 201():105218. PubMed ID: 31610148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benznidazole, itraconazole and their combination in the treatment of acute experimental chagas disease in dogs.
    Cunha ELA; Torchelsen FKVDS; Cunha LM; de Oliveira MT; Fonseca KDS; Vieira PMA; Carneiro CM; de Lana M
    Exp Parasitol; 2019 Sep; 204():107711. PubMed ID: 31254494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trypanosoma cruzi: susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain.
    Camandaroba EL; Reis EA; Gonçalves MS; Reis MG; Andrade SG
    Rev Soc Bras Med Trop; 2003; 36(2):201-9. PubMed ID: 12806455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.